and the downregulation of pro-apoptotic molecules such as Bax. 9 Our previous study has shown that v-crk avian sarcoma virus CT-10 oncogene homolog-like (CrkL), 10 an adaptor protein which can bind
Rap guanine nucleotide exchange factor 1 (C3G) in the integrin pathway, 1, 11 has the effects of cell pro-survival and anti-apoptosis on H9C2 cardiomyocytes. 10, 11 The CrkL effects on cell pro-survival and anti-apoptosis may be mediated via C3G. On the other hand, as a guanine nucleotide exchange factor in the integrin pathway, 1 C3G was found to be expressed in H9C2 cardiomyocytes and rat peri-infarct myocardium. 11, 12 We have also demonstrated that overexpression of C3G can promote cell survival and alleviate hypoxia and reoxygenation (H/R)-induced survival inhibition and apoptosis in H9C2 cardiomyocytes. 11 However, it is not known if silencing of C3G increases cell survival inhibition and apoptosis, and aggravates the injuries induced by H/R, and whether the C3G silence induced myocyte injuries can be reduced by overexpression of C3G in the cardiomyocytes through regulation of p-ERK1/2 and Bax.
The integrin pathway is a novel therapeutic target for cardiovascular diseases due to its component C3G as a potential intervention molecule. In this experimental study, all 13 endogenous gene transcriptions of C3G isoforms were silenced by a small hairpin RNA interference (shRNA), which targets all of C3G isoform gene transcriptions in rat-derived H9C2 cardiomyocytes. Silencing of C3G was disclosed to increase the cell survival inhibition and apoptosis, and aggravate the injuries induced by H/R in the H9C2 cardiomyocytes via regulation of p-ERK1/2 and Bax. Overexpression of human C3G (hC3G) reduced the injuries induced by C3G silence via regulation of p-ERK1/2 and Bax.
| RE SULTS

| Expression of C3G mRNA
Rat C3G mRNA in the cardiomyocytes was declined after the treatment of H/R in the blank, non-target (NT) shRNA, C3G shRNA, and C3G shRNA + hC3G groups (All P < 0.05; Figure 1A ,B). Rat C3G mRNA in the cardiomyocytes was significantly lower in the C3G
shRNA and C3G shRNA + hC3G groups than in the blank and NT shRNA groups, no matter whether the cardiomyocytes were treated with or without H/R (All P < 0.05; Figure 1A ,B). Furthermore, human C3G mRNA level in the cardiomyocytes was higher in the C3G
shRNA + hC3G group as compared with the NT shRNA and C3G
shRNA groups, this finding was similar in cardiomyocytes which were treated with or without H/R (All P < 0.05; Figure 1B ).
| Expression of C3G, p-ERK1/2 and Bax proteins
Decreased C3G and p-ERK1/2 and increased Bax protein levels were found in the cardiomyocytes subjected to H/R treatment in the blank, NT shRNA, C3G shRNA and C3G shRNA + hC3G groups (All P < 0.05; Figure 2A ,B). Decreased C3G and p-ERK1/2 and elevated Bax protein levels of the cardiomyocytes were also found in the C3G
shRNA group when compared with the blank and NT shRNA groups (All P < 0.05; Figure 2A ,B). Cardiomyocyte C3G and p-ERK1/2 levels were higher and Bax protein level was lower in the C3G shRNA + hC3G group than in the NT shRNA and C3G shRNA groups (All P < 0.05; Figure 2B ). These results were not dependent on the H/R treatment of cardiomyocytes.
| Proliferative rate of H9C2 cardiomyocytes
As indicated in Figure 3A ,B, H/R reduced the proliferative rate of cardiomyocytes in the blank, NT shRNA, C3G shRNA and C3G
shRNA + hC3G groups (All P < 0.05; Figure 3A ,B). In contrast, overexpression of hC3G increased the proliferative rate of cardiomyocytes with or without treatment by H/R (All P < 0.05; Figure 3B ). Figure 4A ,B show that H/R could increase the apoptotic rate of cardiomyocytes in the blank, NT shRNA, C3G shRNA and C3G shRNA + hC3G groups (All P < 0.05; Figure 4A ,B). The apoptotic rate of cardiomyocytes in the C3G shRNA + hC3G group was reduced as compared to the respective apoptotic rate in the NT shRNA and C3G
| Apoptotic rate of H9C2 cardiomyocytes
shRNA groups, no matter whether the cardiomyocytes were treated with or without H/R (All P < 0.05; Figure 4B ). Rat C3G protein has 13 different isoforms. Each of them is translated from rat C3G gene transcript variants correspondingly, and acts as a guanine nucleotide exchange factor in the integrin pathway, 13 and could be a part of remodelling mechanisms involved in infarcted myocardium. 12 It is shown that overexpression of C3G can promote cell survival and anti-apoptosis mechanisms in the rat-derived H9C2
| D ISCUSS I ON
cardiomyocytes. 11 However, little is known as to whether silencing C3G could regulate cell survival inhibition and apoptosis, and whether the injuries induced by C3G silence in the cardiomyocytes can be mitigated by overexpression of C3G.
Additionally, there is some available evidence that demonstrates that other components of the integrin pathway such as integrin β1 subunit, 6 FAK, 8 severe dilated cardiomyopathy and spontaneous heart failure which result from cardiomyocyte survival inhibition and apoptosis 8, [22] [23] [24] and reduction of pro-survival molecules such as ERK1/2 and AKT in their cardiomyocytes with knockout of above corresponding genes. 25, 26 When these mice with knockout of integrin β1 subunit or FAK exclusively in their cardiomyocytes were induced by isoproterenol, 22 angiotensin II, 20 pressure overload 16, 20 or myocardial infarction, 6, 8 ischaemic cardiomyopathy after myocardial infarction and chronic congestive heart failure in these mice were evidently accentuated. This was due to increased cardiomyocyte survival inhibition and apoptosis modifications and reduced pro-survival molecules such as ERK1/2 and AKT with the gene knockout. 25, 26 Similarly, knockout of the integrin β1 subunit 22 or FAK 8 in the cardiomyocytes were disclosed to deteriorate the cell survival inhibition and apoptosis induced by isoproterenol or H/R, because of
The expression of C3G mRNA in H9C2 cardiomyocytes examined by reverse transcription polymerase chain reaction. A, M, DNA marker; Blank, blank group; NT shRNA, non-target small hairpin RNA interference group; C3G shRNA, C3G small hairpin RNA interference group; Blank + H/R, blank + hypoxia/reoxygenation group; NT shRNA + H/R, non-target small hairpin RNA interference + hypoxia/ reoxygenation group; C3G shRNA + H/R, C3G small hairpin RNA interference + hypoxia/reoxygenation group. *P < 0.05 vs blank and NT shRNA groups; † P < 0.05 vs C3G shRNA, blank + H/R and NT shRNA + H/R groups. Data are expressed as mean values ± SD, n = 7. B, M, DNA marker; NT shRNA, non-target small hairpin RNA interference group; C3G shRNA, C3G small hairpin RNA interference group; C3G shRNA + hC3G, C3G small hairpin RNA interference + human C3G overexpression group; NT shRNA + H/R, non-target small hairpin RNA interference + hypoxia/ reoxygenation group; C3G shRNA + H/R, C3G small hairpin RNA interference + hypoxia/reoxygenation group; C3G shRNA + hC3G + H/R, C3G small hairpin RNA interference + human C3G overexpression + hypoxia/reoxygenation group. *P < 0.05 vs NT shRNA group; † P < 0.05 vs C3G
shRNA group and NT shRNA + H/R group; ‡ P < 0.05 vs C3G shRNA + hC3G group; § P < 0.05 vs C3G shRNA + H/R group. Data were expressed as mean values ± SD, n = 7
decrease in the pro-survival molecules such as ERK1/2 and AKT. 9, 25 Thus, integrin β1 subunit, 6 The key findings of our current study are consistent with the previous study results. 6, 8, 16, 18, 20, 21 Nevertheless, like knockout of integrin pathway components such as integrin β1 subunit, FAK and ILK, 6, 8, 16, 18, 20, 21 silencing of all C3G isoforms could also lead to cardiomyocyte survival inhibition and apoptosis and exacerbate its injuries induced by H/R via upregulation of pro-apoptotic molecule Bax and downregulation of pro-survival molecule p-ERK1/2. To the best of our knowledge, this is the first study to prove this conclusion. Furthermore, our present study confirmed for the first time that overexpression of human C3G can decrease cell survival inhibition and apoptosis and relieve the injuries induced by C3G silence in the rat-derived H9C2 cardiomyocytes via upregulation of p-ERK1/2 and downregulation of Bax.
+ H/R, blank + hypoxia/reoxygenation group; NT shRNA + H/R, non-target small hairpin RNA interference + hypoxia/reoxygenation group; C3G shRNA + H/R, C3G small hairpin RNA interference + hypoxia/reoxygenation group. *P < 0.05 vs blank and NT shRNA groups; † P < 0.05 vs C3G shRNA, blank + H/R and NT shRNA + H/R groups. Data were expressed as mean values ± SD, n = 7. B, NT shRNA, non-target small hairpin RNA interference group; C3G shRNA, C3G small hairpin RNA interference group; C3G shRNA + hC3G, C3G small hairpin RNA interference + human C3G overexpression group; NT shRNA + H/R, non-target small hairpin RNA interference + hypoxia/reoxygenation group; C3G shRNA + H/R, C3G small hairpin RNA interference + hypoxia/reoxygenation group; C3G shRNA + hC3G + H/R, C3G small hairpin RNA interference + human C3G overexpression + hypoxia/reoxygenation group. *P < 0.05 vs NT shRNA group; † P < 0.05 vs C3G
The proliferative rate of H9C2 cardiomyocytes examined by tetrazolium-based colorimetric assay. A, Blank, blank group; NT shRNA, non-target small hairpin RNA interference group; C3G shRNA, C3G small hairpin RNA interference group; Blank + H/R, blank + hypoxia/reoxygenation group; NT shRNA + H/R, non-target small hairpin RNA interference + hypoxia/ reoxygenation group; C3G shRNA + H/R, C3G small hairpin RNA interference + hypoxia/reoxygenation group. *P < 0.05 vs blank and NT shRNA groups; † P < 0.05 vs C3G shRNA, blank + H/R and NT shRNA + H/R groups. Data were expressed as mean values ± SD, n = 10. B, NT shRNA, non-target small hairpin RNA interference group; C3G shRNA, C3G small hairpin RNA interference group; C3G shRNA + hC3G, C3G small hairpin RNA interference + human C3G overexpression group; NT shRNA + H/R, non-target small hairpin RNA interference + hypoxia/reoxygenation group; C3G shRNA + H/R, C3G small hairpin RNA interference + hypoxia/ reoxygenation group; C3G shRNA + hC3G + H/R, C3G small hairpin RNA interference + human C3G overexpression + hypoxia/ reoxygenation group. *P < 0.05 vs NT shRNA group; † P < 0.05 vs C3G shRNA group and NT shRNA + H/R group; ‡ P < 0.05 vs C3G
shRNA + hC3G group; § P < 0.05 vs C3G shRNA + H/R group. Data were expressed as mean values ± SD, n = 10 shRNA targeting sequence listed in Table 1 Table 1 was also cloned into the GV248-GFP lentiviral vectors and used as a negative control. The C3G shRNA and NT shRNA recombinant lentiviral vectors were packaged into lentiviruses, respectively, in 293T cells by use of a Lentivector Expression System (Genechem Co., Ltd, Shanghai, China), and selected in the presence of puromycin (1.5 μg/mL), respectively. 10 DNA sequencing results confirmed
| MATERIAL S AND ME THODS
| Construction of C3G shRNA lentivirus
The apoptotic rate of H9C2 cardiomyocytes examined by flow cytometry. A, Blank, blank group; NT shRNA, non-target small hairpin RNA interference group; C3G shRNA, C3G small hairpin RNA interference group; Blank + H/R, blank + hypoxia/reoxygenation group; NT shRNA + H/R, non-target small hairpin RNA interference + hypoxia/reoxygenation group; C3G shRNA + H/R, C3G small hairpin RNA interference + hypoxia/reoxygenation group. *P < 0.05 vs blank and NT shRNA groups; † P < 0.05 vs C3G shRNA, blank + H/R and NT shRNA + H/R groups. Data were expressed as mean values ± SD, n = 7. B, NT shRNA, non-target small hairpin RNA interference group; C3G shRNA, C3G small hairpin RNA interference group; C3G shRNA + hC3G, C3G small hairpin RNA interference + human C3G overexpression group; NT shRNA + H/R, non-target small hairpin RNA interference + hypoxia/reoxygenation group; C3G shRNA + H/R, C3G small hairpin RNA interference + hypoxia/reoxygenation group; C3G shRNA + hC3G + H/R, C3G small hairpin RNA interference + human C3G overexpression + hypoxia/reoxygenation group. *P < 0.05 vs NT shRNA group; † P < 0.05 vs C3G shRNA group and NT shRNA + H/R group; ‡ P < 0.05 vs C3G
shRNA + hC3G group; § P < 0.05 vs C3G shRNA + H/R group. Data were expressed as mean values ± SD, n = 7
shRNA or genes Sequences
Size of products (bp) Tm (°C)
Rat C3G shRNA Sense:
NT shRNA Sense: 5′-TTCTCCGAACGTGTCACGT-3′ -62
Rat C3G Sense: 5′-CAGGATGGACAGCAGACAGA-3′
58
Anti-sense: 5′-CTGCGGTGTCTGGTAGAACA-3′
Rat β-actin Sense: 5′-AGATGACCCAGATCATGTTTGA-3′
55
Anti-sense: 5′-TTGGCATAGAGGTCTTTA-3′
Human C3G Sense: 5′-CCAGGTCTCAAAGGCAGAAG-3′
57
Anti-sense: 5′-CTTCTGAGTTCACGCCTTCC-3′
C3G shRNA, C3G small hairpin RNA interference recombinant lentivirus; NT shRNA, non-target small hairpin RNA interference recombinant lentivirus.
TA B L E 1
The target nucleotide sequences of C3G shRNA and NT shRNA and the nucleotide sequences and Tm values of the primers of C3G and β-actin genes that the C3G shRNA interference sequence targeting all of the C3G transcript variant's mRNA was successfully inserted into the recombinant lentiviruses.
| H9C2
cardiomyocyte culture, treatment with C3G shRNA lentivirus, pCXN2-flag-hC3G plasmid and hypoxia/reoxygenation H9C2 cardiomyocytes were cultured as described previously. 10 An equal number of the cardiomyocytes at approximately 60%
confluence was infected and transfected, respectively, with NT shRNA + pCXN2-flag, C3G shRNA + pCXN2-flag, and C3G shRNA + pCXN2-flag-hC3G (hC3G overexpression eukaryotic recombinant plasmid, which was generously provided by Prof. Shinya
Tanaka at Hokkaido University in Japan to Dr. Hua Linghu at
Chongqing Medical University in China). The methods of infection and transfection were the same as described previously.
10
The H9C2 cells were divided into NT shRNA, C3G shRNA, and C3G shRNA + hC3G groups. Two parts were prepared for each group and treated either with or without H/R. The method of H/R treatment was the same as described previously. 10 Finally, the cells were randomly divided into NT shRNA, C3G shRNA, C3G
shRNA + hC3G, NT shRNA + H/R, C3G shRNA + H/R, and C3G
shRNA + hC3G + H/R groups. In another protocol, the cells were 
| RT-PCR examination of C3G mRNA
Seventy-two hours after infection and transfection, the total RNA was isolated, quantified, transcribed reversely into cDNA. 10 One microliter of cDNA generated was amplified using specific primers designed for hC3G, rat C3G for all its isoforms and rat β-actin genes, respectively. The nucleotide sequences and Tm values for all primers are listed in Table 1 . The electrophoretic band intensity of RT-PCR products was analyzed as described previously. 
| Western blot examination of C3G, p-ERK1/2 and Bax proteins
Seventy-two hours after infection and transfection, the cells were collected and lysed. The protein was isolated and its concentration was
gauged. An equal amount of protein was separated by electrophoresis and transferred to a polyvinylidene difluoride membrane. Non-specific sites were blocked as described previously. 10 The membrane was then Boster Biosynthesis Biotechnology Co., Wuhan, China) for 2 hours at 37°C. The immunoreactive band was then watched, and its intensity was determined. 10 The density of C3G, p-ERK1/2 and Bax proteins in relation to β-actin was expressed as C3G/β-actin, p-ERK1/2/β-actin and Bax/β-actin, respectively, which represented the relative expression level of C3G, p-ERK1/2 and Bax proteins, respectively.
| MTT assay of H9C2 cardiomyocyte viability
At the appointed time points (24, 72 hours) after infection and transfection, MTT working solution was added to cells in each well plate.
The cells continued to be incubated for another 4 hours at 37°C.
The supernatant was removed. Dimethyl sulfoxide was then added to each cell. The well plate was shaken for 30 minutes at room temperature. The absorbance of the samples was then detected. 10 The proliferative rate was calculated as (absorbance at 72 hours -absorbance at 24 hours)/absorbance at 24 hours, and expressed as a percentage.
| Flow cytometry examination of H9C2 cardiomyocyte apoptosis
Seventy-two hours after infection and transfection, the apoptotic and necrotic cells were labeled with annexin V-phycoerythrin (PE) and 7-aminoactinomycin D (7-AAD), respectively. Then the fluorescence-labeled cells were sorted by flow cytometry. 10 The cells with annexin-PE positive and 7-AAD negative were determined as the apoptotic cells. The apoptotic rate was calculated as the percentage of the number of the annexin-PE positive and 7-AAD negative cells over the number of the total cells.
| Statistical analysis
Data are expressed as mean values ± standard deviation (SD). All analyses were performed using the SPSS22.0 statistical software (IBM Corporation, Armonk, NY, USA). The statistical significance among groups was judged by one-way ANOVA, then, in case of significance, by a two-sided Tukey test for multiple comparisons. A two-tailed value of P < 0.05 was deemed statistically significant. Shinya Tanaka (Hokkaido University in Japan) for providing the recombinant plasmids including pCXN2-flag and pCXN2-flag-hC3G.
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